Vanguard Group Inc Gritstone Bio, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,733,791 shares of GRTS stock, worth $3.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,733,791

Previous 4,416,292 7.19%

Holding current value

$3.46 Million

Previous $9.01 Million 35.03%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.96 - $2.9 $622,298 - $920,747	317,499 Added 7.19%	4,733,791 $12.2 Million
Q4 2023 Feb 14, 2024	BUY	$1.28 - $2.85 $458,336 - $1.02 Million	358,075 Added 8.82%	4,416,292 $9.01 Million
Q3 2023 Nov 14, 2023	BUY	$1.19 - $2.26 $10,965 - $20,825	9,215 Added 0.23%	4,058,217 $6.98 Million
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.03 $644,250 - $1.18 Million	388,103 Added 10.6%	4,049,002 $7.9 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.74 $1.01 Million - $1.77 Million	474,593 Added 14.89%	3,660,899 $10.2 Million

Q4 2022 Feb 10, 2023	BUY	$2.35 - $3.92 $191,125 - $318,813	81,330 Added 2.62%	3,186,306 $11 Million
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $454,342 - $877,287	184,692 Added 6.32%	3,104,976 $7.98 Million
Q2 2022 Aug 12, 2022	BUY	$1.77 - $4.34 $328,471 - $805,404	185,577 Added 6.79%	2,920,284 $7.07 Million
Q1 2022 May 13, 2022	BUY	$4.03 - $12.19 $94,451 - $285,697	23,437 Added 0.86%	2,734,707 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $6.5 Million - $10.2 Million	742,246 Added 37.7%	2,711,270 $34.9 Million
Q3 2021 Nov 12, 2021	BUY	$6.41 - $13.54 $3.5 Million - $7.39 Million	545,775 Added 38.35%	1,969,024 $21.3 Million
Q2 2021 Aug 13, 2021	BUY	$8.13 - $10.2 $11.6 Million - $14.5 Million	1,423,249 New	1,423,249 $13 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

45.6M

Call Options Held

861K

Put Options Held

4.52M

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $53.3M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Gritstone Bio, Inc. Transaction History